Big Data Analytics Research Projects Target Cancer, Genomics
Several recently announced collaborations between academic research institutions and big data analytics vendors powering advanced discovery technologies will bring the power of big data to new studies that may have significant impacts on future therapies and treatments. With oncology and genomics in the spotlight, personalized medicine is poised to take a leap forward as researchers […]
Global Genomics Group (G3) and GNS Healthcare Report Preliminary Results of Largest-Ever Study Linking Biomarkers with Coronary Artery Disease
Study Applies GNS’s Causal Machine Learning to G3’s G3LOBAL DatabaseTM Study Demonstrates Proof of Concept of Approach with Identification of Known Coronary Disease-Associated Pathway ATLANTA, Ga. and CAMBRIDGE, Mass. – Jan. 8, 2016 – Global Genomics Group (G3), a life sciences company that leverages large-scale genomic and molecular disease profiles to develop life-changing diagnostics and therapeutics, […]
GNS Healthcare Secures $10M Series C Financing to Accelerate Development of New, Data-Driven Solutions at the Intersection of Precision Medicine and Population Health
New Investors Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund LP Join Cambia Health Solutions, Heritage Provider Network, Mitsui CAMBRIDGE, Mass. – Dec. 8, 2015 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, […]
PharmiWeb.com: New Data at ASH 2015 from the Multiple Myeloma Research Foundation
The Multiple Myeloma Research Foundation (MMRF) is presenting today new data from the MMRF CoMMpass StudySM – the most comprehensive long-term genomic study ever conducted in myeloma and one that may significantly advance the understanding of multiple myeloma. The data provide significant insights into the genetics of multiple myeloma and the potential association to patient […]
Center for Medicine in the Public Interest Says Biotech Game-Changers Meet to Promote Earlier Access to Lifesaving Medicines for Critically Ill Patients
Group Is Working to Make Better Use of Big Data Analysis to Match Patients to Best Treatments in Real Time Meeting February 18th in New York Will Coincide with the Lincoln Center Premiere of the Documentary “Surviving Terminal Cancer” NEW YORK–(BUSINESS WIRE)–Center for Medicine in the Public Interest says a new alliance supporting accelerated access to […]
WUSA9: Genomics – The Power to Predict – Special WUSA9 Coverage of Inova and GNS aired on January 24, 2015
A television special on groundbreaking work by the Inova Translational Medicine Institute (ITMI) in Northern Virginia will feature collaboration with GNS Healthcare that uses genomics to prevent preterm births. “Genomics – The Power to Predict” aired on January 24, 2015 on the CBS affiliate in Washington, DC, News Channel 9. Watch the full show here.
Modern Healthcare: The newest new thing: Obama’s precision medicine initiative – GNS CEO quoted
“Delivering on precision medicine’s promise is the culmination of many previous technological and policy efforts”, noted Colin Hill, co-founder and CEO of GNS Healthcare, a company specializing in precision analytics. Read the complete article here…
Big Data Analytics Research Projects Target Cancer, Genomics
Several recently announced collaborations between academic research institutions and big data analytics vendors powering advanced discovery technologies will bring the power of big data to new studies that may have significant impacts on future therapies and treatments. Read the complete article here…
MMRF, GNS Healthcare to Collaborate on CoMMpass Study
GNS Healthcare and the Multiple Myeloma Research Foundation announced today an agreement to use GNS’ informatics solutions to explore genomic and clinical data from the Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile, or CoMMpass, study. Read the complete article here…
The Multiple Myeloma Research Foundation and GNS Healthcare Announce Collaboration to Identify Potential New Multiple Myeloma Therapies
Initiative will deploy predictive big data analytics to analyze patient data from landmark CoMMpass Study™ to speed drug discovery and development for patients with multiple myeloma CAMBRIDGE, Mass. and NORWALK, Conn. – Jan. 7, 2015 – GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, and the […]